Suchergebnisse - (Subject:"Comparative Study")

PubPharm (215)

1

Intensity-modulated radiotherapy improves survival and reduces treatment time in squamous cell carcinoma of the anus : A National Cancer Data Base study

enthalten in: Cancer | 2018

von Elson, J. | Kachnic, L. | Kharofa, J.

2

Muscle mass at the time of diagnosis of nonmetastatic colon cancer and early discontinuation of chemotherapy, delays, and dose reductions on adjuvant FOLFOX : The C-SCANS study

enthalten in: Cancer | 2017

von Cespedes Feliciano, E. | Lee, V. | Prado, C. | +6

3

Unresectable intrahepatic cholangiocarcinoma : Systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy alone

enthalten in: Cancer | 2016

von Konstantinidis, I. | Groot Koerkamp, B. | Do, R. | +9

4

A randomized phase 2 study comparing EC or CMF versus nab-paclitaxel plus capecitabine as adjuvant chemotherapy for nonfrail elderly patients with moderate to high-risk early breast cancer (ICE II-GBG 52)

enthalten in: Cancer | 2015

von von Minckwitz, G. | Conrad, B. | Reimer, T. | +18

5

Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck : 10-year update and subset analysis

enthalten in: Cancer | 2015

von Iyer, N. | Tan, D. | Tan, V. | +10

ErratumIn: Cancer. 2015 Oct 1;121(19):3560. - PMID 26383792

6

Intermittent versus continuous erlotinib with concomitant modified "XELOX" (q3W) in first-line treatment of metastatic colorectal cancer : correlation with serum amphiregulin and transforming growth factor alpha

enthalten in: Cancer | 2013

von Ma, B. | Chan, S. | Ho, W. | +11

7

Comparison of adverse events during 5-fluorouracil versus 5-fluorouracil/oxaliplatin adjuvant chemotherapy for stage III colon cancer : a population-based analysis

enthalten in: Cancer | 2012

von Sanoff, H. | Carpenter, W. | Freburger, J. | +6

8

Comparative and cost-effectiveness of oxaliplatin-based or irinotecan-based regimens compared with 5-fluorouracil/leucovorin alone among US elderly stage IV colon cancer patients

enthalten in: Cancer | 2012

von Mullins, C. | Hsiao, F. | Onukwugha, E. | +2

9

Racial disparities in receipt and comparative effectiveness of oxaliplatin for stage III colon cancer in older adults

enthalten in: Cancer | 2012

von Mack, C. | Carpenter, W. | Meyer, A. | +2

10

Prognostic web-based models for stage II and III colon cancer : A population and clinical trials-based validation of numeracy and adjuvant! online

enthalten in: Cancer | 2011

von Gill, S. | Loprinzi, C. | Kennecke, H. | +8

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[22]